A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease

NCT01485172 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: ropinirole monotherapy
DRUG: placebo monotherapy

Sponsor

GlaxoSmithKline